Health Products

APO-Norflox 400 mg (2015-08-25)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
MC8181APO-Norflox 400 mg
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
TabletDIN 02229524Norfloxacin 400 mg

Introduction

Affected Products

APO-Norflox 400 mg

Reason

Levels of excipients crospovidone and magnesium stereate do not meet the quantities specified in the regulatory filing.

Depth of distribution

Wholesalers, Distributors, and Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime